![](https://wp-static.smartkarma.com/../assets/uploaded/2022/01/China51JobIncAdrJLMagRareEarthCoLtdHangSengTechIndexCIMBGroupHoldingsHangzhouBioerTechnologyKwgPrope.jpg)
In today’s briefing:
- 51job (JOB US): 27.6% Reduction In Terms
- JL Mag Rare Earth A/H Trading – Set for a Tepid Debut
- A Share Fizzle – HK Tech Bullish Base
- 51job’s Lowered Privatisation Bid
- 6 New $ Deals incl. CIMB, IRFC, CCB; Macro; Rating Changes; New Issues; Talking Heads; Top Gainer…
- Bioer IPO: Currently Holding Strong but Would Growth Rates Sustain Post-COVID?
- Morning Views Asia: KWG Living Group, Shui On Land, Sino-Ocean Service
51job (JOB US): 27.6% Reduction In Terms
- Not an overreaction after all. After shares closed down 19.2% on the 8 November, 20% adrift of indicative terms, that appeared overdone.
- Now 51 Job Inc (JOBS US) has announced the Offeror has proposed reducing the merger consideration from US$79.05 in cash per common share to US$57.25.
- Shares closed up, but still at a 14.5% gross spread to terms. The new construct, and the reasons for doing so, are decidedly baffling.
JL Mag Rare Earth A/H Trading – Set for a Tepid Debut
- JL Mag Rare-earth Co. Ltd (JLM) raised around US$544m via its H-shares listing.
- JLM is a producer of high-performance REPMs. It ranked first in the world by high-performance REPM production volume in 2020 with a market share of approximately 14.5%.
- In this note, we look at the allocation results and trading dynamics.
A Share Fizzle – HK Tech Bullish Base
- A share pop a flash in the pan and still shows heavy price action as the bull wedge matures into late January.
- HSI is meeting the fresh short target zone near 24,700 with a minor new low in store for late January.
- HK tech is making strides to bottom as RSI divergence matures but still needs some final strokes for a higher conviction base.
51job’s Lowered Privatisation Bid
- The consortium’s updated transaction has lowered the offer price -27.6% to $57.25 in cash per ADS, a 24.92% premium to the last trading price (11 January 2022).
- The combination of the dramatically lower price, spurious justification for lowering the price and the shares recently trading higher than the revised price is unlikely to win over minorities.
- Meeting the two-thirds shareholder approval threshold is likely a challenge due to the need to convince around 27% of disinterested shareholders to vote in favour of the transaction.
6 New $ Deals incl. CIMB, IRFC, CCB; Macro; Rating Changes; New Issues; Talking Heads; Top Gainer…
Bioer IPO: Currently Holding Strong but Would Growth Rates Sustain Post-COVID?
- Bioer designs, manufactures and sells three categories of PCR products: instruments, reagents and consumables. With the spread of COVID-19, the company experienced strong growth in revenue and margin improvements.
- The company has filed for an IPO to list its shares on the Hong Kong Stock Exchange and plans to raise proceeds of around US$200m
- Strong growth in Bioer’s revenue over the last two years was predominantly driven by the spread of COVID-19. We are concerned on the company’s ability to maintain its revenues post-COVID.
Morning Views Asia: KWG Living Group, Shui On Land, Sino-Ocean Service
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.
Before it’s here, it’s on Smartkarma